CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-08 | Sanders Corazon (Corsee) D. Director | Sale | −1,485 | $51.65 | $77K | 9,570 |
| 2023-06-07 | Ray Amrit Director | Grant or award | +3,860 | 12,280 | ||
| 2023-06-07 | Ray Amrit Director | Grant or award · Stock Option (Right to Buy) | +7,110 | 7,110 | ||
| 2023-06-07 | Fust Matthew K Director | Grant or award | +3,860 | 30,355 | ||
| 2023-06-07 | Fust Matthew K Director | Returned to the company | −3,300 | $51.82 | $171K | 27,055 |
| 2023-06-07 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +7,110 | 7,110 | ||
| 2023-06-07 | Sanders Corazon (Corsee) D. Director | Grant or award | +3,860 | 11,055 | ||
| 2023-06-07 | Sanders Corazon (Corsee) D. Director | Grant or award · Stock Option (Right to Buy) | +7,110 | 7,110 | ||
| 2023-06-07 | SULIMAN SHEHNAAZ Director | Grant or award | +3,860 | 14,855 | ||
| 2023-06-07 | SULIMAN SHEHNAAZ Director | Grant or award · Stock Option (Right to Buy) | +7,110 | 7,110 | ||
| 2023-06-07 | NARACHI MICHAEL Director | Grant or award | +3,860 | 21,605 | ||
| 2023-06-07 | NARACHI MICHAEL Director | Grant or award · Common Stock | +7,110 | 7,110 | ||
| 2023-06-07 | Dunsire Deborah Director | Grant or award | +3,860 | 19,730 | ||
| 2023-06-07 | Dunsire Deborah Director | Grant or award · Stock Option (Right to Buy) | +7,110 | 7,110 | ||
| 2023-06-07 | WELCH DANIEL G Director | Grant or award | +3,860 | 21,605 | ||
| 2023-06-07 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +7,110 | 7,110 | ||
| 2023-05-18 | Pinion John Richard See Remarks | Sale | −2,012 | $50.00 | $101K | 74,744 |
| 2023-05-09 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Option exercise | +3,000 | $21.00 | $63K | 30,747 |
| 2023-05-09 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 5,000 | ||
| 2023-05-04 | Parschauer Karah Herdman EVP and Chief Legal Officer | Sale | −4,378 | $45.00 | $197K | 51,982 |
Page 12 of 21 · 410 trades